E
Ironwood Pharmaceuticals, Inc. IRWD
$1.55 -$0.06-3.73% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -7.89M -32.34M 880.00K -2.46M 9.21M
Total Depreciation and Amortization 2.34M 2.38M 2.41M 2.44M 2.04M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 88.38M 91.63M 100.28M 99.15M 104.56M
Change in Net Operating Assets -52.85M 16.85M -24.00K 25.04M 30.93M
Cash from Operations 29.99M 78.52M 103.55M 124.17M 146.74M
Capital Expenditure -49.00K -105.00K -142.00K -353.00K -386.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -3.98M -26.55M
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -49.00K -105.00K -142.00K -4.33M -26.94M
Total Debt Issued 0.00 150.00M 150.00M 150.00M 150.00M
Total Debt Repaid -40.00M -240.00M -265.00M -275.00M -325.00M
Issuance of Common Stock 297.00K 958.00K 11.01M 11.81M 11.82M
Repurchase of Common Stock 0.00 -121.00K -737.00K -737.00K -737.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -2.25M -2.25M -2.25M -29.06M -26.90M
Cash from Financing -41.95M -91.41M -106.97M -142.99M -190.82M
Foreign Exchange rate Adjustments -659.00K -63.00K -32.00K -103.00K -80.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -12.67M -13.06M -3.60M -23.25M -71.10M